Navigation Links
Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
Date:1/31/2008

XI'AN, China, Jan. 31 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar", "Company"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that the Company is raising its guidance for 2007 revenue to $15.8 million. The Company previously announced 2007 revenue guidance to be in the range of $12 - $14 million.

"We are proud to announce the first year operating our new veterinary medicine facility we exceeded our revenue target for 2007. Our success in achieving our record revenue is the result of expanding our product line with 62 new drug approvals, increasing our market penetration and implementing an aggressive marketing campaign," commented Skystar's Chief Executive Officer, Mr. Weibing Lu. "We look forward to another strong year for 2008 as our new vaccine facility is expected to begin large-scale production in the second half of the year."

About Skystar Bio-Pharmaceutical

Skystar Bio-Pharmaceutical Company is a China-based producer and distributor of vaccines, microorganisms and veterinary medication to cure and prevent disease in poultry, livestock, birds and pets. The Company's product line consists of more than 100 products with over 50 additional products in the developmental stage. Skystar has formed strategic sales distribution networks throughout China. The Company recently completed construction of new state-of-the-art bio-pharmaceutical facilities covering an area of almost eight acres. The new facilities meet or exceed all Good Manufacturing Practice (GMP) Certification Standards and have received GMP Certification from the Chinese government. For additional information, please visit http://www.skystarbio-pharmaceutical.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains certain "forward-
'/>"/>

SOURCE Skystar Bio-Pharmaceutical Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
2. Pearl Therapeutics Raises $15.5 Million in Private Financing
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
5. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
6. VisEn Medical Raises $7 Million in Series B Financing
7. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
8. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
9. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
10. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
11. Anesiva Raises $45 Million in Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ublication of a study led by Yuntao Wu, assistant ...of Molecular and Microbiology, the medical communi...an immunodeficiency virus (HIV) attacks cells in t...fected more than 33 million people worldwide in 20...cs. , In the Sept. 5 issue of the journal Cell ...
(Date:9/5/2008)...s much of a hold on the human imagination, or on h...popular uses money, medals, jewelry and more gol...980s, when Masatake Haruta and Graham Hutchings in...een considered inactive, could be an extraordinari...erature oxidation of CO and Hutchings the hydrochl...
(Date:9/5/2008).... 5 /- Men living in Western,Oregon w...arged prostate,now have the option of out-patient,..., Inc. is pleased to announce that a network of do...hrough LIFE(TM) (Laser Induced,Flow Enhancement) l...H),that quickly and gently eliminates swollen pros...
(Date:9/5/2008)...ry Strategy for Belinostat in PTCL, COPENHAGEN, D...Target,A/S (OMX: TOPO) announced that a positive r...ol Assessment (SPA) for a phase III trial for beli... pivotal trial is to enrol,approximately 120 patie...,designation was granted for the development of be...
Breaking Biology Technology:Researchers decode viral process that prepares cells for HIV infection 2Scientists peel away the mystery behind gold's catalytic prowess 2Scientists peel away the mystery behind gold's catalytic prowess 3Scientists peel away the mystery behind gold's catalytic prowess 4Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 3Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 4Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 5
...is the ninth in a series of articles on developing...logy sectors. The most recent article focused on w...idea is developed. Lawyers and accountants are on ...d. The entity is formed. The name has been chosen....ired and independent contractors have been contrac...
...Gen Technologies , a Madison-based DNA analysis co...oyees in advance of a second round of venture capi...esident of corporate development and chief scienti...ere let go to control costs as the company prepare...d that Joe Shaw, former CEO of OpGen, now is servi...
...ut five weeks after the launch of wireless Interne...stomers still expressed a preference for the wirel... Mad City Broadband , which provides wireless Inte...itol Square and at Dane County Regional Airport ,...dband service will add indoor wireless access poin...
...aurie Benson, CEO of Inacom Information Systems ,...ne A Million awards program, scheduled for May 21...l, mentoring, and other resources to women entrepr... million level, including technology entrepreneurs... behind Inacom, a $70 million information technolo...
Other Biology Technology:Early Stage, Step 9: Raising capital in the securities landscape 2Early Stage, Step 9: Raising capital in the securities landscape 3Early Stage, Step 9: Raising capital in the securities landscape 4OpGen layoffs precede another funding round 2Visions: Benson touts embedded innovation 2Visions: Benson touts embedded innovation 3Visions: Benson touts embedded innovation 4
(Date:9/4/2008)...ique partnership between Syracuse University and t...ccess to life-saving vaccines for children living ...d. The Institute recently awarded $250,000 to a t...nt professor of chemistry in the College of Arts a...tetanus and rotavirus, a severe form of diarrhea t...
(Date:9/4/2008)...sville, Ala. -- A team including researchers at th...ogether with colleagues from a number of other org...is of genomic variation in the brain cancer gliobl...r Genome Atlas (TCGA) research network, a collabor...te and the National Human Genome Research Institut...
(Date:9/4/2008)... COLD SPRING HARBOR, N.Y. (Sept. 4, 2008) A va...s and animalshave biological rhythms, where the ti...ses is naturally adjusted to allow them to adapt a...onditions. In recent years, significant advances ...f these rhythms and how they translate into modifi...
(Date:9/4/2008)...IDENCE New research from Rhode Island Hospital fo...M) can contribute to mild neurodegeneration with f...first study to show that obesity can cause neurode...Alzheimer,s Disease Volume 15:1 (September 2008) ...r Suzanne de la Monte, MD, MPH, of Rhode Island Ho...
Breaking Biology News(10 mins):Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2RS 26A Inc Announces It Has Joined Radiology Oncology Systems Inc 28ROS 29 and Acceletronics Inc in a Strategic Alliance to Better Serve Its Cu 5943 1RS 26A Inc Announces It Has Joined Radiology Oncology Systems Inc 28ROS 29 and Acceletronics Inc in a Strategic Alliance to Better Serve Its Cu 5943 2RS 26A Inc Announces It Has Joined Radiology Oncology Systems Inc 28ROS 29 and Acceletronics Inc in a Strategic Alliance to Better Serve Its Cu 5943 3 2440 Million Forfeiture Sought in Nation Wide Internet Pharmacy Case 5939 1 2440 Million Forfeiture Sought in Nation Wide Internet Pharmacy Case 5939 2This Thanksgiving Give the Gift of Good Health Remind Family and Friends to Get a Flu Shot 814 1This Thanksgiving Give the Gift of Good Health Remind Family and Friends to Get a Flu Shot 814 2This Thanksgiving Give the Gift of Good Health Remind Family and Friends to Get a Flu Shot 814 3Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 1Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 2Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 3Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 4Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 5Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 1749 6
...opes was found guilty of violating a Tennessee sta...hough an appeals court later reversed his convicti...s, joined by later laws promoting "scientific crea..." The battle to keep religiously based explanatio...t of the science curriculum continues unabated. A...
...have worked to develop a number of vaccines to hel...are not intended to prevent cancer; rather, they a...umors. Unlike traditional chemotherapy, vaccines h...gh degree of efficacy. , To date, these vaccines h... of the body,s most critical immune responders, th...
... a “night owl?report more pathological symptoms re...nity to compensate for their nocturnal sleeplessne...o gain more total sleep time, according to a study...of Clinical Sleep Medicine (JCSM). , The study, au...nford University, consisted of 312 patients, who w...
... produces proteins that appear to attack the stoma...the bugs starve to death. , The gene,s role in cr...to U.S. Department of Agriculture and Purdue Unive... function. They made the finding as they investiga...nsect damage. , "This is a different kind of de...
Other Biology News:Fighting to keep Darwin in the classroom 2Fighting to keep Darwin in the classroom 3Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine 2Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine 3'Night owls' report more insomnia-related symptoms 2Wheat can fatally starve insect predators 2Wheat can fatally starve insect predators 3
ID clarifier: With ethidium bromide (50 μg/ml)
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition
RNA Sample Buffer is a convenient, premixed, formamide-containing sample buffer for experimental samples and Perfect RNA Markers. This 2X sample buffer needs no dilution and is suitable for native an
...se RAW 264. 7 cells were cultured in DMEM with 4 m...e of growth. In order to keep the antigens in the...nol. The cells are arrayed on a 12-well (5 mm) ad...fically treated to enhance cellular attachment and...
Biology Products: